Keyphrases
Platelet-derived Growth factor-BB (PDGF-BB)
100%
Neoadjuvant
100%
Rectal Carcinoma
100%
Capecitabine
100%
Adjuvant Irradiation
100%
Serum Levels
50%
Chemoradiation
50%
Tumor
25%
Substantial Change
25%
Platelet Count
25%
Clinical Benefit
25%
Angiogenic
25%
Antiangiogenic Activity
25%
Antiangiogenic Factors
25%
Antiangiogenic
25%
Rest Period
25%
Angiogenic Factors
25%
Combination Treatment
25%
Chemotherapy Regimen
25%
Pelvic Irradiation
25%
Metronomic Chemotherapy
25%
Reduced Dose
25%
Low-dose Chemotherapy
25%
Nursing and Health Professions
Low Drug Dose
100%
Vasculotropin
100%
Adjuvant
100%
Capecitabine
100%
Rectum Carcinoma
100%
Platelet Derived Growth Factor
100%
Blood Level
50%
Angiogenic Factor
50%
Neoplasm
25%
Platelet Count
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
100%
Vasculotropin
100%
Platelet Derived Growth Factor
100%
Capecitabine
100%
Rectum Carcinoma
100%
Antiangiogenic
75%
Angiogenic Factor
50%
Chemotherapy
25%
Neoplasm
25%
Chemotherapy Regimens
25%
Immunology and Microbiology
Adjuvant
100%
Low Drug Dose
100%
Vasculotropin
100%
Platelet Derived Growth Factor
100%
Blood Level
50%
Angiogenic Factor
50%
Platelet Count
25%
Antiangiogenic Activity
25%
Pelvis
25%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Low Drug Dose
100%
Platelet-Derived Growth Factor
100%
Capecitabine
100%
Blood Level
50%
Platelet Count
25%
Antiangiogenic Activity
25%